Richard Aarnio

6PUBLICATIONS
33CO-AUTHORS
Neurology and neuromuscular diseasesPharmacogenomicsMedical biochemistry - lipidsMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2025
Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [11C]UCB-J-PET Imaging.

Amelie Luoma, Markus Matilainen, Jouni Mikael Tuisku

|Jun 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku

|Jun 13, 2024
New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state.

Richard Aarnio, Anna Kirjavainen, Johan Rajander

|Sep 27, 2022
Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites.

Joachim Brumberg, Richard Aarnio, Anton Forsberg

|Feb 02, 2022
Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation.

S K Vainio, A M Dickens, M Matilainen

|Nov 03, 2021
Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability.

Tatu Kantonen, Laura Pekkarinen, Tomi Karjalainen

Pageof 1

Frequent Collaborators

2 joint publications

Jouni Tuisku

2 joint publications

Markus Matilainen

2 joint publications

Juha O Rinne

2 joint publications

Laura M Airas